John W. Rogers Jr. - Ariel Appreciation Fund 13F Activity & Position Changes (Q2 2023)

As of Jun 30, 2023, the Ariel Appreciation Fund portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Aug 14, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2023, the filing reported:

New Buys - Core Laboratories Inc., CME Group Inc., New Oriental Education & Techno, iQIYI, Inc., iShares Russell Mid-cap Value E, and 1 more

Increases - iShares MSCI ACWI ex U.S. ETF, ADT Inc., Bank of America Corporation, The Carlyle Group Inc., Charles River Laboratories Inte, and 27 more

Reductions - Ambev S.A., AFLAC Incorporated, Affiliated Managers Group, Inc., Adtalem Global Education Inc., Axalta, and 65 more

Complete Exits - Berkshire Hathaway Inc. New, Cardinal Health, Inc., Novartis AG

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q2 2023	ABEV Ambev S.A.	Ambev S.A.	Sell	-60,770	-4.2%	$4.36M	1,370,556
Q2 2023	ACWX iShares MSCI ACWI ex U.S. ETF	iShares MSCI ACWI ex U.S. ETF	Buy	+22,232	+19.8%	$6.61M	134,395
Q2 2023	ADT ADT Inc.	ADT Inc.	Buy	+2,543,989	+13.6%	$128.45M	21,302,098
Q2 2023	AFL AFLAC Incorporated	AFLAC Incorporated	Sell	-279,816	-31.4%	$42.65M	611,020
Q2 2023	AMG Affiliated Managers Group, Inc.	Affiliated Managers Group, Inc.	Sell	-24,991	-2.3%	$159.96M	1,067,169
Q2 2023	ATGE Adtalem Global Education Inc.	Adtalem Global Education Inc.	Sell	-187,902	-4.9%	$124.42M	3,623,194
Q2 2023	AXTA Axalta	Axalta	Sell	-808,431	-12.6%	$184.59M	5,626,019
Q2 2023	BAC Bank of America Corporation	Bank of America Corporation	Buy	+23,917	+19.7%	$4.17M	145,371
Q2 2023	BAP Credicorp	Credicorp	Sell	-30,943	-2.1%	$210.56M	1,426,147
Q2 2023	BCO Brinks Company (The)	Brinks Company (The)	Sell	-87,355	-4.4%	$128.46M	1,893,912
Q2 2023	BIDU Baidu, Inc.	Baidu, Inc.	Sell	-78,555	-2.8%	$377.36M	2,756,228
Q2 2023	BIO Bio-Rad Laboratories, Inc.	Bio-Rad Laboratories, Inc.	Sell	-27,404	-86.2%	$1.67M	4,393
Q2 2023	BMY Bristol-Myers Squibb Company	Bristol-Myers Squibb Company	Sell	-25,255	-3.2%	$48.68M	761,208
Q2 2023	BOKF BOK Financial Corporation	BOK Financial Corporation	Sell	-199,947	-7.8%	$191.19M	2,366,764
Q2 2023	BRC Brady Corporation	Brady Corporation	Sell	-689	-0.2%	$13.51M	283,920
Q2 2023	BRK-B Berkshire Hathaway Inc. New	Berkshire Hathaway Inc. New	Sell - Position Exit	-12,950	-100.0%	$0.00	-
Q2 2023	BSAC Banco Santander - Chile	Banco Santander - Chile	Sell	-31,885	-2.3%	$25.58M	1,357,101
Q2 2023	BWA BorgWarner Inc.	BorgWarner Inc.	Sell	-278,588	-17.3%	$65.33M	1,335,619
Q2 2023	BYD Boyd Gaming Corporation	Boyd Gaming Corporation	Sell	-342,299	-9.9%	$215.94M	3,112,821
Q2 2023	CAH Cardinal Health, Inc.	Cardinal Health, Inc.	Sell - Position Exit	-258,578	-100.0%	$0.00	-
Q2 2023	CBRE CBRE Group Inc	CBRE Group Inc	Sell	-468,615	-36.1%	$66.82M	827,963
Q2 2023	CG The Carlyle Group Inc.	The Carlyle Group Inc.	Buy	+2,413,794	+79.6%	$174.01M	5,446,414
Q2 2023	CHKP Check Point	Check Point	Sell	-13,244	-2.6%	$61.52M	489,741
Q2 2023	CLB Core Laboratories Inc.	Core Laboratories Inc.	Buy - Position Entry	+9,631,723	-	$223.94M	9,631,723
Q2 2023	CME CME Group Inc.	CME Group Inc.	Buy - Position Entry	+15,518	-	$2.88M	15,518
Q2 2023	CRL Charles River Laboratories Inte	Charles River Laboratories Inte	Buy	+364,786	+53.4%	$220.31M	1,047,840
Q2 2023	DNB Dun & Bradstreet Holdings, Inc.	Dun & Bradstreet Holdings, Inc.	Buy	+600,978	+29.3%	$30.65M	2,649,391
Q2 2023	EDU New Oriental Education & Techno	New Oriental Education & Techno	Buy - Position Entry	+216,727	-	$8.56M	216,727
Q2 2023	EQC Equity	Equity	Buy	+259,555	+3.9%	$141.12M	6,965,293
Q2 2023	EVR Evercore Inc.	Evercore Inc.	Buy	+4,934	+3.2%	$19.94M	161,356

Page 1 of 4